An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy

BACKGROUND: Loss of the tumor suppressor PTEN is common in prostate cancer and may have prognostic significance. The authors examined PTEN and additional protein markers in primary tumors from patients with high-risk, localized prostate cancer who received adjuvant docetaxel in a prospective multice...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Antonarakis, Emmanuel S., Keizman, Daniel, Zhang, Zhe, Gurel, Bora, Lotan, Tamara L., Hicks, Jessica L., Fedor, Helen L., Carducci, Michael A., De Marzo, Angelo M., Eisenberger, Mario A.
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572534/
https://ncbi.nlm.nih.gov/pubmed/22674438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27689
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker